EVALUATION OF THE QUANTOS® POWDER DOSING SYSTEM FOR CAPSULE MANUFACTURING IN A HOSPITAL PHARMACY
PP-041
EXTEMPORANEOUS PREPARATION OF ORAL LIQUID FORMULATION OF CAPECITABINA
PP-040
SODIUM THIOSULFATE IN CUTANEOUS NECROSIS BY CALCIPHYLAXIS TREATMENT. A CASE REPORT
PP-037
RISK OF MICROBIAL CONTAMINATION OF PHARMACY STERILE PREPARATIONS: A RISK BASED DECISION MATRIX
PP-036
STABILITY STUDY OF 5 MG/ML OXYBUTYNIN ORAL SUSPENSION IN SYRSPEND
PP-035
THE OUTCOME OF MICROBIOLOGICAL MONITORING IN CYTOTOXIC DRUG PREPARATION
PP-034
USE OF AUTOLOGOUS SERUM EYE DROPS PREPARED IN A HOSPITAL PHARMACY SERVICE
PP-033
STABILITY STUDY OF 20 MG/ML PAEDIATRIC AMIODARONE ORAL SUSPENSION IN SYRSPEND
PP-030
EFFECTIVENESS OF A TOPICAL SIROLIMUS FORMULATION IN PATIENTS WITH TUBEROUS SCLEROSIS
PP-029
STUDY OF RADIONUCLIDE IMPURITIES IN 18F-METILCHOLINE: SETUP OF THE MEASUREMENT GEOMETRY FOR HIGH PURITY GERMANIUM GAMMA RAY SPECTROMETER
PP-028
ARE COMMERCIAL MULTI-DOSE FORMULATIONS THE BEST SOLUTION? A SPECTROSCOPIC QUALITY STUDY OF CYCLOPHOSPHAMIDE
PP-027
EVALUATION OF THE QUALITY OF THE PARENTERAL NUTRITION PREPARED ON THE NEONATOLOGY WARD
PP-025
99MTC MACROAGGREGATED ALBUMIN (99MTC-MAA): VALIDATION OF PREPARATION PROTOCOLS FOR LUNG SCINTIGRAPHY IN PAEDIATRIC PATIENTS
PP-023
GRAVIMETRIC AND SPECTROPHOTOMETRIC QUANTIFICATION OF PRAVASTATIN SODIUM SALT EXTEMPORANEOUS SOLUTIONS ADMINISTERED THROUGH FEEDING TUBE: EFFECT OF PREPARATION METHODS
PP-022
PAEDIATRIC CHEMOTHERAPY PREPARATION: AN A PRIORI RISK ASSESSMENT
